SONA Asset Management (US)’s Drugs Made In America Acquisition Corp DMAA Stock Holding History

SONA Asset Management (US)’s Portfolio DMAA Stock Details DMAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.71M	Buy	+162,795	New	+$1.7M	0.04%	217

Other funds holding DMAA

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SONA Asset Management (US)'s DMAA Position: Q1 2026 in Review

SONA Asset Management (US) opened a new position in Drugs Made In America Acquisition Corp (DMAA) in Q1 2026: 162,795 shares worth $1.71M. The stake represents 0.04% of the portfolio and ranks #217 among its holdings.

39 funds tracked by Wall St. Rank hold DMAA as of Q1 2026.

SONA Asset Management (US) held 162,795 shares of Drugs Made In America Acquisition Corp worth $1.71M as of Q1 2026.
Drugs Made In America Acquisition Corp was a new SONA Asset Management (US) position in Q1 2026.
Drugs Made In America Acquisition Corp made up 0.04% of SONA Asset Management (US)'s portfolio in Q1 2026, its #217 holding.
39 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp as of Q1 2026.

Based on SONA Asset Management (US)'s 13F filing for Q1 2026, filed 15 May 2026.